Upstream / Downstream


Explore pathways related to this product.

Research More. Spend Less.

Spend $650 or more and get 20% off*

(*Offer valid in the US only. Expires June 30, 2017)



Find answers on our FAQs page.


PhosphoSitePlus® Resource

  • Additional protein information
  • Analytical tools


Product Description

The High Mobility Group (HMG) Proteins Antibody Sampler Kit provides an economical means of detecting total protein from the HMG family members including HMGA1, HMGB1, HMGB2, HMGN1 and HMGN2. The kit contains enough primary antibody to perform four western blots per primary antibody.

Specificity / Sensitivity

Each antibody in this kit recognizes endogenous levels of total protein for the specified target and does not cross-react with other family members. HMGA1 (D6A4) XP® Rabbit mAb recognizes isoforms 1a and 1b.

Source / Purification

Monoclonal antibody is produced by immunizing animals with synthetic peptides corresponding to residues surrounding Gly68 of human HMGA1, Ala137 of Human HMGB1, Glu169 of human HMGB2, Val32 of human HMGN1, or Asp74 of human HMGN2 protein.

High mobility group (HMG) proteins are a superfamily of abundant and ubiquitous nuclear proteins that bind DNA without sequence specificity and induce structural changes to the chromatin fiber to regulate access to the underlying DNA (1). HMGA1, formerly known as HMG-I/Y, belongs to a family of high mobility group proteins known as HMGA. HMGA proteins are considered architectural transcription factors; they do not have direct transcriptional activation capacity, but instead regulate gene expression by changing DNA conformation through binding to AT-rich regions in the DNA and/or direct interaction with other transcription factors (2). HMGA1 is highly expressed during embryogenesis and in embryonic stem cells, but not in fully differentiated adult tissues (3,4). High mobility group protein B1 (HMGB1) and high mobility group protein B2 (HMGB2) belong to a family of highly conserved proteins that contain HMG box domains (5). HMGB1 is a widely expressed and highly abundant protein (6). HMGB2 is widely expressed during embryonic development, but it is restricted to lymphoid organs and testis in adult animals (7). While expression varies, the biochemical properties of the different family members may be indistinguishable. HMGB proteins are recruited by and help facilitate the assembly of site-specific DNA binding proteins to their cognate binding sites in chromatin. For example, HMGB1 and HMGB2 facilitate the binding of Hox proteins, Oct proteins, p53, Rel proteins, and steroid hormone receptor proteins to their target gene promoters (5,6). In addition to their functions in the nucleus, HMGB proteins play a significant role in extracellular signaling associated with inflammation. HMGB1 is massively released into the extracellular environment during cell necrosis, but not apoptosis. Extracellular HMGB1 "alarms" the innate immune system by acting as a chemoattractant for inflammatory cells triggering activation of T cells and dendritic cells. In addition, activated monocytes, macrophages, and dendritic cells also secrete HMGB1 (6). HMGB2 is secreted by myeloid cells and promotes proliferation and migration of endothelial cells by binding to the receptor for advanced glycation end products (RAGE) (8). The HMGN family of proteins, which includes five members (HMGN1-5) (1) function in transcriptional regulation and are recruited to gene promoters by transcription factors, such as estrogen receptor α (ERα), serum responsive factor (SRF), and PITX2, where they can facilitate either gene activation or repression (9-11). The expression of HMGN1 (also known as HMG14) and HMGN2 (also known as HMG17) is tightly linked to cellular differentiation. HMGN1 and HMNG2 are ubiquitous and highly expressed in all embryonic tissues. During mouse embryogenesis, expression is down-regulated throughout the embryo, except in committed but continuously renewing cell types undergoing active differentiation, such as the basal layer of the epithelium and kidney cells undergoing mesenchyme to epithelium transition (12,13).

1.  Hock, R. et al. (2007) Trends Cell Biol 17, 72-9.

2.  Thomas, J.O. and Travers, A.A. (2001) Trends Biochem Sci 26, 167-74.

3.  Cleynen, I. and Van de Ven, W.J. (2008) Int J Oncol 32, 289-305.

4.  Müller, S. et al. (2004) J Intern Med 255, 332-43.

5.  Chiappetta, G. et al. (1996) Oncogene 13, 2439-46.

6.  Ronfani, L. et al. (2001) Development 128, 1265-73.

7.  Ben-Porath, I. et al. (2008) Nat Genet 40, 499-507.

8.  Pusterla, T. et al. (2009) Autoimmunity 42, 308-10.

9.  Zhu, N. and Hansen, U. (2007) Mol Cell Biol 27, 8859-73.

10.  Amen, M. et al. (2008) Nucleic Acids Res 36, 462-76.

11.  Belova, G.I. et al. (2008) J Biol Chem 283, 8080-8.

12.  Furusawa, T. et al. (2006) Mol Cell Biol 26, 592-604.

13.  Lehtonen, S. and Lehtonen, E. (2001) Differentiation 67, 154-63.

Entrez-Gene Id 3159 , 3146 , 3148 , 3150 , 3151
Swiss-Prot Acc. P17096 , P09429 , P26583 , P05114 , P05204

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.

High Mobility Group (HMG) Proteins Antibody Sampler Kit